In addition, it was reported that immunity could influence chemotherapy and radiotherapy by increasing tumor-suppressor factor such as HMGB1 or enhancing the expression of PD-L1 to hamper anti-tumor immunity in different cancers (24). Here, HMGB1 is linked to cancer.